To use all functions of this page, please activate cookies in your browser.
With an accout for my.bionity.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
- My watch list
- My saved searches
- My saved topics
- My newsletter
2,822 Current news from the ressort cooperationrss
|You can refine your search further. Select from the filter options on the left to narrow down your results.|
Polaris Biology and Tetramer Shop combine forces to accelerate state-of-the-art single-cell analysis capacity
Two MedTech companies, Polaris Biology of China and Tetramer Shop of Denmark, announce a strategic partnership to co-develop and distribute technologies that accelerate T cell science. First on the agenda is to commercialize metal-labelled MHC tetramers for distribution in China. Conventional ...
Covid-19 poses major challenges for developing and mass-producing vaccines and medicines in existing production facilities
Siemens and Exyte join forces to offer end-to-end solutions for the biopharmaceutical industry by combining the digitalization expertise of Siemens with the innovation boost from Exyte. Against the background of the current challenges associated with the Covid-19 pandemic, pharmaceutical ...
Company will focus on process development and improvements for manufacturing Baylor’s Covid-19 vaccine candidates
Merck and Baylor College of Medicine, Houston, Texas, USA, announced an extension of their ongoing collaboration to advance a manufacturing platform to fight Covid-19, designed to accelerate transition to Phase 1 clinical trials. “Vaccine manufacturing is extremely complicated, so we are ...
Antibodies were generated from convalescing COVID-19 patients
Evotec SE announced that its Seattle-based subsidiary Just – Evotec Biologics, Inc. has entered into a partnership with Ology Bioservices, Inc. (Ology Bio) for the evaluation and analytical characterisation of antibodies against SARS-CoV-2. This work falls under a contract awarded to Ology Bio by ...
Evotec continues development of the beta cell programme initially on its own
Evotec SE announced that it will regain global development and commercialisation rights to the iPSC-based programme for the treatment of diabetes developed under collaboration agreement with Sanofi. Evotec has built a unique platform for iPSC-based drug discovery and cell therapy covering the ...
Joint team reduced process development time to two months from a year
Merck and The Jenner Institute announced that the Jenner Institute has laid the foundation for large-scale production of its Covid-19 vaccine candidate, ChAdOx1 nCoV-19. With patients enrolled for clinical trials for this vaccine, rapid development of the large-scale manufacturing process is a ...
Companies have set up a Joint Task Force
Sanofi and GSK announce that they have signed a letter of intent to develop an adjuvanted vaccine for COVID-19, using innovative technology from both companies, to help address the ongoing pandemic. Sanofi will contribute its S-protein COVID-19 antigen, which is based on recombinant DNA ...
BioNTech SE and Pfizer Inc. disclosed additional details of their collaboration to advance candidates from BioNTech’s mRNA vaccine program, previously announced on March 17, 2020. The collaboration aims to rapidly advance multiple COVID-19 vaccine candidates into human clinical testing based on ...
Evotec SE announced that Evotec GT, with operations in Austria, has established a long-term research alliance with Takeda to support Takeda’s growing number of research stage gene therapy discovery programmes. Under the alliance, Evotec will support multiple Takeda programmes targeting conditions ...
Companies expect to initiate clinical testing in 2020
Neurimmune AG and Ethris GmbH announced an exclusive partnership to develop mRNA-encoded, neutralizing anti-SARS-CoV-2 antibodies administered by inhalation for the treatment of Covid-19. The collaboration brings together Neurimmune’s expertise in developing human antibodies based on ...